Research Article
COVID-19 and Obesity: An Epidemiologic Analysis of the Brazilian Data
Table 2
Deaths by COVID-19 within preexisting diseases and age group.
| | Age (years) | Χ2 | | Cramer’s V | <60 | ≥60 | Total |
| All deaths | 16130 | 45541 | 61671 | 14031.14 | <0.001 | 0.4770 | Obesity | 1124 | 1120 | 2244 | 0.007 | 0.933 | 0.0018 | Cardiovascular disease | 4167 | 19562 | 23729 | 9993.29 | <0.001 | 0.6490 | Diabetes | 4175 | 14804 | 18979 | 5958.31 | <0.001 | 0.5603 | Asthma | 414 | 778 | 1192 | 111.154 | <0.001 | 0.3054 | Pneumopathy | 459 | 2622 | 3081 | 1519.43 | <0.001 | 0.7023 | Neurological disease | 2355 | 8350 | 10705 | 2094.64 | <0.001 | 0.4423 | Immunosuppression | 798 | 1355 | 2153 | 144.552 | <0.001 | 0.2591 | Chronic kidney disease | 971 | 2863 | 3834 | 935.15 | <0.001 | 0.4939 | Hypertension | 1694 | 6778 | 8472 | 3048.6 | <0.001 | 0.5999 | Cancer | 563 | 1592 | 2155 | 491.342 | <0.001 | 0.4775 |
|
|
Goodness-of-fit chi-square test. Cramer’s V > 0.1. |